StockTipsArenaBeta

BUY Sun Pharmaceutical Industries Ltd. — Arun Kumar Mantri

BUYSun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries share price target & all analyst calls

byArun Kumar MantriHorizon: NA (inferred BTST)20 Jul 2026, 3:29 pm ISTvia CNBC Awaaz.

Entry₹1,956.4Inferred
Target₹1,992
Total upside +1.82% (call closed)
Stop loss₹1,939-0.89% risk
At expiry₹1,962.121 Jul 2026, 3:20 pm
Expired+0.29%
Follow Arun Kumar Mantri for new calls(17% target hit, 102 closed calls)Get alertsWatch SUNPHARMA for new buy/sell callsGet alertsSee 3 active BTST picks this session

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 21 Jul 2026
2 supporting0 opposing
Supports the BUY call (2)

4 advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·15 Jul · 5d ago

Sun Pharmaceutical Industries Limited has received approval to manufacture and market a generic version of semaglutide in South Africa, expanding its product portfolio and market access.

NSE · Press Release·15 Jul · 6d ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Sun Pharmaceutical Industries

All analyst calls on Sun Pharmaceutical Industries

More from Arun Kumar Mantri

Every call and its outcome